Deinove (XPAR:ALDEI) Price-to-Tangible-Book : (As of May. 31, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Deinove Price-to-Tangible-Book?

As of today (2024-05-31), Deinove's share price is €0.0265. Deinove's Tangible Book per Share of Jun. 2022 for the quarter that ended in Jun. 2022 was €-0.52. Hence, Deinove's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Deinove's Price-to-Tangible-Book or its related term are showing as below:

XPAR:ALDEI's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.77
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Deinove's share price is €0.0265. Deinove's Book Value per Sharefor the quarter that ended in Jun. 2022 was €-0.45. Hence, Deinove's P/B Ratio of today is .

Deinove Price-to-Tangible-Book Historical Data

The historical data trend for Deinove's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deinove Price-to-Tangible-Book Chart

Deinove Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Price-to-Tangible-Book

Get a 7-Day Free Trial

Deinove Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Deinove's Price-to-Tangible-Book

For the Biotechnology subindustry, Deinove's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Deinove's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Deinove's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Deinove's Price-to-Tangible-Book falls into.

Deinove Price-to-Tangible-Book Calculation

Deinove's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2022 )
	=	0.0265	/	-0.523
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Deinove Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Deinove's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Deinove (XPAR:ALDEI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Deinove SA (XPAR:ALDEI) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

1682 rue de la Valsiere, Cap Sigma, ZAC Euromedecine II, Grabels, FRA, 34790

Website

http://www.deinove.com

Deinove SA is a biotechnology company engaged in the development of technologies and molecules for the health, nutrition and cosmetics industries. It is developing in two areas of activity, New-generation anti-infective ANTIBIOTICS which involves the search for novel anti-infective molecules and the development of new generations of drugs capable of responding to the challenges of antibiotic resistance; and BIOACTIVES, natural active ingredients discovers, develops and produces bioactives, active ingredients of natural origin from its bacterial biodiversity bank, to invent the new generation of sustainable cosmetics and intends to quickly bring its know-how and its products to other fields, such as nutrition and health.

Deinove (XPAR:ALDEI) Headlines

No Headlines